Description

DLPLTFGGGTK (TFA) is a surrogate peptide for pembrolizumab identification[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)—-C52H81F3N12O18—-[1]Chiu HH, et al. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS. Anal Chim Acta. 2018;1019:93-102.—-1219.26–99.18–O=C(N[C@@H](CC(C)C)C(N1[C@@H](CCC1)C(N[C@@H](CC(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC2=CC=CC=C2)C(NCC(NCC(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N.OC(C(F)(F)F)=O–Others–H2O : 100 mg/mL (ultrasonic)–Others—-Others–Peptides